Francesmary Mudugno

22PUBLICATIONS
282CO-AUTHORS
Predictive and prognostic markersChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Feb 26, 2025
Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression Subtypes.

Lindsay J Collin, Kara L Cushing-Haugen, Kathryn L Terry

|Jun 12, 2024
Variables Affecting CA15.3 Tumor Antigen Expression and Antibodies against It in Female National Health and Nutritional Survey Participants.

Daniel W Cramer, Allison F Vitonis, Raina N Fichorova

|Jun 05, 2024
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.

Flurina A M Saner, Kazuaki Takahashi, Timothy Budden

|May 23, 2023
Folate Intake and Ovarian Cancer Risk among Women with Endometriosis: A Case-Control Study from the Ovarian Cancer Association Consortium.

Kate Gersekowski, Torukiri I Ibiebele, Jennifer A Doherty

|Feb 16, 2023
Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy.

Alexander J Cole, Santiago Panesso-Gómez, Jaynish S Shah

|Jan 23, 2023
Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.

Zhuxuan Fu, Maria Mori Brooks, Sarah Irvin

Pageof 4